BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4619689)

  • 1. The importance of donor protection by furosemide and steroids in cadaveric kidney preservation.
    McCabe R; Stevens LE; Subramanian A; Lattes C; Fitzpatrick HF
    Proc Clin Dial Transplant Forum; 1973; 3():85-7. PubMed ID: 4619689
    [No Abstract]   [Full Text] [Related]  

  • 2. Cadaver Kidney transplantation. Effect of hypotension and donor pretreatment with methylprednisolone and phenoxybenzamine.
    Toledo-Pereyra LH; Simmons RL; Olson LC; Najarian JS
    Minn Med; 1979 Mar; 62(3):159-61. PubMed ID: 370540
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of risk factors in acute tubular necrosis following cadaver kidney transplantation.
    Garnier JL; Mercatello A; Long D; Zannier A; Faure JL; Touraine JL; Moskovichenko JF; Dubernard JM; Traeger J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2068-70. PubMed ID: 2881385
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of acute tubular necrosis (ATN) by furosemide and steroids in cadaveric kidney recovery.
    McCabe R; Stevens LE; Subramamian A; Lattes C; Hashim GM
    Am J Surg; 1975 Mar; 129(3):246-8. PubMed ID: 1091177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Ischaemia times and phenoxybenzamine in human cadaver-kidney donors.
    Sterling WA; Kirk KA; Turner ME
    Lancet; 1975 Jan; 1(7898):108. PubMed ID: 46000
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal management of warm ischemic kidneys prior to hypothermic preservation.
    Toledo-Pereyra LH; Moberg AW; Najarian JS
    Transplant Proc; 1974 Sep; 6(3):279-82. PubMed ID: 4606875
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of organ preservation in cadaver kidney transplantation.
    Toledo-Pereyra LH; Simmons RL; Moberg AW; Buselmeier TJ; Kjellstrand CM; Najarian JS
    Proc Eur Dial Transplant Assoc; 1976; 12():492-500. PubMed ID: 778842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment of cadaver donors with methylprednisolone in human renal allografts.
    Chatterjee SN; Terasaki PI; Fine S; Schulman B; Smith R; Fine RN
    Surg Gynecol Obstet; 1977 Nov; 145(5):729-32. PubMed ID: 333644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal preservation.
    Belzer FO
    N Engl J Med; 1974 Aug; 291(8):402-4. PubMed ID: 4603173
    [No Abstract]   [Full Text] [Related]  

  • 10. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
    Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S
    Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The results of cadaver kidney transplantation with prolonged cold ischemia time.
    Haberal M; Gülay H; Arslan G; Bilgin N
    Transplant Proc; 1988 Oct; 20(5):935-7. PubMed ID: 3055534
    [No Abstract]   [Full Text] [Related]  

  • 13. Early donor lymph node procurement and local HLA typing reduce cold ischemia time and risk of acute tubular necrosis in cadaveric kidney transplantation.
    Ziaja J; Król R; Chudek J; Zakliczyńska H; Sekta S; Siekiera U; Wiecek A; Cierpka L
    Transplant Proc; 2006; 38(1):39-41. PubMed ID: 16504658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year experience in the use of double balloon catheter for kidney procurement from non-heart beating donors in cadaveric kidney transplantation.
    Yokoyama I; Uchida K; Tominaga Y; Asano H; Orihara A; Takagi H
    Clin Transplant; 1993 Jun; 7(3):258-62. PubMed ID: 10148845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in acute tubular necrosis and acute renal allograft rejection.
    Matsuno T; Nakagawa K; Sasaki H; Ishine N; Inagaki M; Yagi T; Haisa M; Tanaka N; Sakagami K; Orita K
    Transplant Proc; 1994 Aug; 26(4):2170-3. PubMed ID: 8066712
    [No Abstract]   [Full Text] [Related]  

  • 16. Cadaver organs: limitations and results.
    Haberal M; Karakayali H; Bilgin N; Arslan G; Büyükpamukçu N; Velidedeoğlu E; Turan M; Akkoç H; Moray G; Tezel E
    Transplant Proc; 1996 Feb; 28(1):266-8. PubMed ID: 8644215
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of the donor age effect on kidney transplants.
    Terasaki PI; Gjertson DW; Cecka JM; Takemoto S; Cho YW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):366-72. PubMed ID: 9361925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor pretreatment and organ preservation.
    Bell PR; Quin RO; Calman KC
    Transplant Proc; 1974 Sep; 6(3):245-8. PubMed ID: 4606448
    [No Abstract]   [Full Text] [Related]  

  • 19. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of kidney transplantation from nonheart-beating versus heart-beating cadaveric donors.
    Kokkinos C; Antcliffe D; Nanidis T; Darzi AW; Tekkis P; Papalois V
    Transplantation; 2007 May; 83(9):1193-9. PubMed ID: 17496535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.